Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer

1 Dec 2022

Abstract excerpt

Background: Transmembrane p24 trafficking protein (TMED) family members are implicated in several solid tumors, but their clinical relevance for breast cancer (BC) remains unclear. This study aimed to probe their prognostic values and relations with tumor immunity in BC. Methods: TMED family mRNA expression was assessed in five microarray datasets (GSE65212, GSE42568, GSE5364, GSE22820 and GSE45827) from Gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36618780
DOI: 10.21037/atm-22-5444

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancerPMID 36618780Read ↗

Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human CancerSemantic proximity Read ↗

Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironmentSemantic proximity Read ↗

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous CarcinomaSemantic proximity Read ↗

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor MicroenvironmentSemantic proximity Read ↗

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family based on bioinformatics analysis and in vitro validationSemantic proximity Read ↗

Expression Analysis, Molecular Characterization and Prognostic Evaluation on <i>TMED4</i> and <i>TMED9</i> Gene Expression in GliomaSemantic proximity Read ↗

Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of gliomaSemantic proximity Read ↗

CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental VerificationSemantic proximity Read ↗

A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor SurvivalSemantic proximity Read ↗

TPD52 promotes breast cancer cell migration, invasion and proliferation via activation of the MAPK/ERK signaling pathwaySemantic proximity Read ↗

KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challengesSemantic proximity Read ↗

The effect of DDIT3 on luminal A type breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.